Similar articles for PMID: 31924721

Year	Number of Results
1993	1
1994	2
1997	1
2003	1
2005	1
2007	2
2008	1
2009	1
2010	1
2012	1
2013	4
2014	2
2015	6
2016	8
2017	16
2018	20
2019	22
2020	5
2021	1
2024	0

1

Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements.

Hänscheid H, Lassmann M. Hänscheid H, et al. J Nucl Med. 2020 Jul;61(7):1028-1029. doi: 10.2967/jnumed.119.239970. Epub 2020 Jan 10. J Nucl Med. 2020. PMID: 31924721 Free article. No abstract available.

2

Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.

Violet J, Jackson P, Ferdinandus J, Sandhu S, Akhurst T, Iravani A, Kong G, Kumar AR, Thang SP, Eu P, Scalzo M, Murphy D, Williams S, Hicks RJ, Hofman MS. Violet J, et al. J Nucl Med. 2019 Apr;60(4):517-523. doi: 10.2967/jnumed.118.219352. Epub 2018 Oct 5. J Nucl Med. 2019. PMID: 30291192 Free article. Clinical Trial.

3

Whole-remnant and maximum-voxel SPECT/CT dosimetry in ¹³¹ I-NaI treatments of differentiated thyroid cancer.

Mínguez P, Flux G, Genollá J, Delgado A, Rodeño E, Sjögreen Gleisner K. Mínguez P, et al. Med Phys. 2016 Oct;43(10):5279-5287. doi: 10.1118/1.4961742. Med Phys. 2016. PMID: 28105713

4

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.

Belli ML, Mezzenga E, Di Iorio V, Celli M, Caroli P, Canali E, Matteucci F, Tardelli E, Grassi I, Sansovini M, Nicolini S, Severi S, Cremonesi M, Ferrari M, Paganelli G, Sarnelli A. Belli ML, et al. J Vis Exp. 2020 Apr 24;(158). doi: 10.3791/60477. J Vis Exp. 2020. PMID: 32391816

5

Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.

Wang J, Zang J, Wang H, Liu Q, Li F, Lin Y, Huo L, Jacobson O, Niu G, Fan X, Zhu Z, Chen X. Wang J, et al. Clin Nucl Med. 2019 Jun;44(6):431-438. doi: 10.1097/RLU.0000000000002575. Clin Nucl Med. 2019. PMID: 30985422 Free PMC article.

6

Whole-remnant and maximum-voxel SPECT/CT dosimetry in ¹³¹I-NaI treatments of differentiated thyroid cancer.

Mínguez P, Flux G, Genollá J, Delgado A, Rodeño E, Sjögreen Gleisner K. Mínguez P, et al. Med Phys. 2016 Oct;43(10):5279. doi: 10.1118/1.4961742. Med Phys. 2016. PMID: 27782699

7

Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated ¹⁷⁷Lu-Labeled Folic Acid Using SPECT/CT Imaging of Mice.

Gupta A, Shin JH, Lee MS, Park JY, Kim K, Kim JH, Suh M, Park CR, Kim YJ, Song MG, Jeong JM, Lee DS, Lee YS, Lee JS. Gupta A, et al. Mol Pharm. 2019 Apr 1;16(4):1498-1506. doi: 10.1021/acs.molpharmaceut.8b01125. Epub 2019 Mar 18. Mol Pharm. 2019. PMID: 30821463

8

A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation.

Roth D, Gustafsson J, Sundlöv A, Sjögreen Gleisner K. Roth D, et al. Med Phys. 2018 Nov;45(11):5004-5018. doi: 10.1002/mp.13178. Epub 2018 Oct 8. Med Phys. 2018. PMID: 30199102

9

Multicentre Trials on Standardised Quantitative Imaging and Dosimetry for Radionuclide Therapies.

Lassmann M, Eberlein U, Tran-Gia J. Lassmann M, et al. Clin Oncol (R Coll Radiol). 2021 Feb;33(2):125-130. doi: 10.1016/j.clon.2020.11.008. Epub 2020 Dec 1. Clin Oncol (R Coll Radiol). 2021. PMID: 33277151 Review.

10

Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.

Yadav MP, Ballal S, Tripathi M, Damle NA, Sahoo RK, Seth A, Bal C. Yadav MP, et al. Nucl Med Commun. 2017 Jan;38(1):91-98. doi: 10.1097/MNM.0000000000000606. Nucl Med Commun. 2017. PMID: 27782913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year